Abstract
The synthesized chloroethylnitrosoureas (CENUs), 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU), and methyl-6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-α-D-glucopyranoside (MCNU), have been among the antitumor agents widely used for the treatment of malignant brain tumors [1]. Methods for monitoring responsiveness of brain tumors to CENUs on the basis of a cell-killing mechanism have been needed to enhance therapeutic effectiveness. It is well documented that a DNA repair enzyme O6-methylguanine-DNA methyltransferase (O6-MT), identical to the term O6-alkylguanine-DNA alkyltransferase, eliminates the O6-methylguanine induced by CENUs and reflects the cellular resistance to CENUs in cultured cell strains and xenografted tumors [2–5]. Further in vivo work was warranted to establish a chemoserisitivity index of O6-MT activity. In the present paper, we test the relationship of O6-MT activity and responsiveness to CENUs in xenografted brain tumors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, Yamamoto S, Kageyama N, Handa H, Mogami H, Nishimoto A, Uozumi T, Matsutani M, Nomura K (1986) Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 64: 53–57
Scudiero DA, Meyer SA, Clatterbuck BE, Mattern MR, Ziolkowski CHJ (1984) Sensitivity of human cell strains having different abilities to repair O6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas. Cancer Res 44; 2467–2474
Ikenaga M, Tsujimura T, Chang HR, Fujio C, Zhang YP, Ishizaki K, Kataoka H, Shima A (1987) Comparative analysis of O6-methylguanine methyltransferase activity and cellular sensitivity to alkylating agents in cell strains derived from a variety of animal species. Mutat Res 184: 161–168
Fujio C, Chang HR, Tsujimura T, Ishizaki K, Kitamura H, Ikenaga M (1989) Hypersensitivity of human tumor xenografts laking O6-alkylguanine-DNA alkyl- transferase to the antitumor agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea. Carcinogenesis 10: 351–356
Mineura K, Fushimi S, Kowada M, Isowa G, Ishizaki K, Ikenaga M (1990) Linkage between O6-methylguanine-DNA-methyltransferase activity and cellular resistance to antitumor nitrosoureas in cultured rat brain tumor cell strains. Acta Neurochir (Wien) 103: 62–66
Mineura K, Kuwahara N, Kowada M (to be published) Clinical implication of selective nitrosourea treatment for cerebral gliomas with respect to 06-methyl- guanine-DNA methyltransferase activity. J Neurooncol
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Tokyo
About this chapter
Cite this chapter
Mineura, K., Kuwahara, N., Watanabe, K., Kowada, M. (1991). O6-Methylguanine-DNA Methyltransferase (O6-MT) Activity as an Index of Drug Responsiveness to Antitumor Chloroethylnitrosoureas in Xenografted Brain Tumors. In: Tabuchi, K. (eds) Biological Aspects of Brain Tumors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68150-2_34
Download citation
DOI: https://doi.org/10.1007/978-4-431-68150-2_34
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68152-6
Online ISBN: 978-4-431-68150-2
eBook Packages: Springer Book Archive